PATH Meningitis Vaccine Gets $100M

PATH Meningitis Vaccine Gets $100M

Luke Timmerman, Seattle PI

The GAVI Alliance, the Geneva, Switzerland-based global health organization, said today it has committed $100 million to support the use of a meningitis vaccine developed by Seattle-based PATH.

Read more.